Hyperuricemia Trials in Honolulu, United States
Conditions / Hyperuricemia / Honolulu, United States
Hyperuricemia is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01265264 | Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol | COMPLETED | PHASE2 |
| NCT01336686 | Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout | COMPLETED | PHASE2 |
| NCT05586971 | Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients | COMPLETED | PHASE3 |
| NCT06846515 | Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00995618 | Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia | COMPLETED | PHASE2 |
| NCT05119686 | Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients | COMPLETED | PHASE2 |
| NCT02959918 | Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid | COMPLETED | PHASE2 |
| NCT01052987 | Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia | COMPLETED | PHASE2 |
| NCT01407874 | A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency | COMPLETED | PHASE2 |
| NCT01109121 | Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) | COMPLETED | PHASE2 |